Posted by Michael Wonder on 27 Mar 2024
Ritlecitinib tosylate for the treatment of people 12 years and over with alopecia areata
27 March 2024 - NICE has published final evidence-based recommendations on the use of ritlecitinib tosylate (Litfulo) for the treatment of people 12 years and over with alopecia areata.
Ritlecitinib tosylate is recommended as an option for the treatment of people 12 years and over with severe alopecia areata only if Pfizer provides it according to the commercial arrangement.
